SUMMARY
Medical Device start-up developing a novel Cold Atmospheric Plasma bio-molecule deposition system to speed healing and prevent infections.
AerMedx Health’s Cold Atmospheric Plasma Deposition System is a major advancement in local drug delivery for faster healing and infection treatment. It enables the non-systemic delivery of pure biologics or drugs which are bonded to almost any surface. The AerMedx therapy is a breakthrough treatment for multiple conditions including faster healing of burns, abrasions, Diabetic Foot Ulcers & Venous Stasis Ulcers. It also prevents and treats infections with topical delivery of antibiotics directly to tissue.
STAGE
- Prototype ready, design frozen, animal data, validation testing phase.
- Preparing 510(k) for submission to FDA in Q3 2020.
- Dermatology product commercialization Q2 2021.
- Diabetic Foot Ulcer Commercialization Q4 2021
TECHNOLOGY
- Promotes cell proliferation and healing
- Applies wide range of biologics or drugs
- Bonds to almost any tissue and bone
- Kills bacteria, viruses, spores, biofilms
ACCOMPLISHMENTS
- Joint Development and Commercialization Agreement with Apyx Medical (formerly Bovie Medical)
- Design of plasma/biologic delivery system frozen
- Preparing for human clinical trials
- Validation of 12 active biologic materials bonded to tissues or device surfaces – proteins, antibiotics, polysaccharides, enzymes, human cells
- Highly successful animal trials
- Diabetic ulcer treatment
- Antibiotic treatment of orthopedic infection
- Accelerated burn healing
- 2 broad patents issued - 3 additional applications with office actions
Ready to Ask For Funding for your company?
Post a Funding Request